Clear Labs Raises $21M Series B2 to Expand Clear Safety, World’s Only Automated NGS Platform for Routine Pathogen Testing

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2SxjFIg
via IFTTT